Literature DB >> 22976832

Treatment of disease recurrence after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: a great challenge still to be won.

Franco Locatelli1, Barbarella Lucarelli.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22976832     DOI： 10.1002/pbc.24294

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  3 in total

1.  Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.

Authors:  Hemalatha G Rangarajan; Marcelo S F Pereira; Ruta Brazauskas; Andrew St Martin; Ashleigh Kussman; Ezgi Elmas; Michael R Verneris; Shahinaz M Gadalla; Steven G E Marsh; Sophie Paczesny; Stephen R Spellman; Stephanie J Lee; Dean A Lee
Journal:  Transplant Cell Ther       Date:  2021-08-15

2.  Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.

Authors:  Sachit A Patel; Don W Coulter; Alfred C Grovas; Bruce G Gordon; James L Harper; Phyllis I Warkentin; James L Wisecarver; Warren G Sanger; Peter F Coccia
Journal:  J Pediatr Hematol Oncol       Date:  2014-08       Impact factor: 1.289

3.  Combination of DNA-hypomethylating agent and hematopoietic stem cell transplantation in treatment of juvenile myelomonocytic leukemia: A case report.

Authors:  Yuan Ai; Xiaoxi Lu; Tingting Zhu; Yiping Zhu; Hanmin Liu; Shuwen Sun
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.